BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7011834)

  • 1. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
    Brocard H; Charpin J; Germouty J
    Eur J Respir Dis Suppl; 1980; 111():65-9. PubMed ID: 7011834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral N-acetylcysteine on mucus clearance.
    Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
    Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.
    Aylward M; Maddock J; Dewland P
    Eur J Respir Dis Suppl; 1980; 111():81-9. PubMed ID: 7011835
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
    Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
    Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study.
    Eur J Respir Dis Suppl; 1980; 111():93-108. PubMed ID: 7011836
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.
    Boman G; Bäcker U; Larsson S; Melander B; Wåhlander L
    Eur J Respir Dis; 1983 Aug; 64(6):405-15. PubMed ID: 6350033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [N-acetylcystein in the therapy of chronic bronchitis].
    Reichenberger F; Tamm M
    Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis.
    Rasmussen JB; Glennow C
    Eur Respir J; 1988 Apr; 1(4):351-5. PubMed ID: 3294038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled clinical evaluation of guaimesal in outpatients.
    Jager EG
    Clin Ther; 1989; 11(3):341-62. PubMed ID: 2663163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
    Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
    Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of letosteine activity in the treatment of acute febrile bronchitis in children. Double-blind controlled study versus placebo].
    Nespoli L; Monafo V; Bonetti F; Terracciano L; Savio G
    Minerva Pediatr; 1989 Oct; 41(10):515-20. PubMed ID: 2693929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A multi-center clinical study of N-acetylcysteine on chronic hepatitis B].
    Shi XF; Guo SH; Wu G; Mao Q; Yu YS; Wang JK; Zhang L; Wang ZY; Zhang XQ; Zhang QH; Zhao YR; Zeng WQ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):20-3. PubMed ID: 15670485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The mucolytic effects of acetylcysteine compared with bromhexine and a placebo in patients with chronic bronchitis].
    Heinig JH; Pedersen B; Andersen I; Dalgaard CE; Rasmussen O; Weeke ER; Enk B
    Ugeskr Laeger; 1985 Nov; 147(46):3694-7. PubMed ID: 3907080
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement of mucociliary transport in smokers by mucolytics.
    Olivieri D; Marsico SA; Del Donno M
    Eur J Respir Dis Suppl; 1985; 139():142-5. PubMed ID: 3862608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis.
    Pozzi E; Dolcetti A; Orlandi O; Cirianni C; Moreo G; Piacenza G; Rampulla C; Fugazza L; Scarpazza G
    Arzneimittelforschung; 1994 Dec; 44(12A):1495-8. PubMed ID: 7857350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study.
    Jackson IM; Barnes J; Cooksey P
    J Int Med Res; 1984; 12(3):198-206. PubMed ID: 6376210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
    Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y
    Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
    Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis.
    Dunlay J; Reinhardt R; Roi LD
    J Fam Pract; 1987 Aug; 25(2):137-41. PubMed ID: 3302093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of N-acetylcysteine on asthma exacerbation.
    Aliyali M; Poorhasan Amiri A; Sharifpoor A; Zalli F
    Iran J Allergy Asthma Immunol; 2010 Jun; 9(2):103-9. PubMed ID: 20683104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.